adenosine monophosphate has been researched along with Acute Hypercapnic Respiratory Failure in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 11 (91.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bitnun, A; Casalino, M; Gauda, EB; Gryn, D; Kulkarni, T; Paopongsawan, P; Sarhan, MA | 1 |
| Aldir, I; Campos, L; Carmo, E; Carmo, I; Carvalho, A; Coelho, L; Correia, J; Falcão, F; Farinha, H; Fonseca, C; Mansinho, K; Martins, AP; Mendes, D; Miranda, AC; Mirco, A; Póvoa, P; Soares, J; Solano, M; Viegas, E | 1 |
| Carugati, M; Castaldo, G; Faccioli, P; Franzetti, M; Iemoli, E; Longoni, E; Molteni, C; Ormas, V; Pandolfo, A; Piconi, S; Pozzetti, U | 1 |
| Azmy, V; Benson, J; Love, K; Steele, R | 1 |
| Demirkan, K; Yalçın, N | 1 |
| Burwick, RM; Dellapiana, G; Leggett, C; Naqvi, M; Tholemeier, L | 1 |
| Arthur, CM; Clarke, S; Josephson, CD; Lough, C; MacDonald, H; Roback, JD; Rodriguez, Z; Shane, AL; Stowell, SR; Suthar, M; Verkerke, H; Wolf, M; Wrammert, J; Zimmerman, MG | 1 |
| Alcobendas, R; Álvarez-Rojas, E; de la Serna, O; Laplaza-González, M; Murias, S; Quintana-Ortega, C; Remesal, A; Ruiz de Valbuena, M; Udaondo, C | 1 |
| Farley, TM; Sabers, AJ; Williams, AL | 1 |
| Trkulja, V | 1 |
| Aballi, S; Andersen, JT; Aukrust, P; Barratt-Due, A; Berg, Å; Blomberg, B; Dahl, TB; Dalgard, O; Dudman, S; Dyrhol-Riise, AM; Eiken, R; Ernst, G; Finbråten, AK; Fladeby, C; Hannula, R; Haugli, M; Heggelund, L; Hoel, H; Hoff, DAL; Holten, AR; Johannessen, A; Kåsine, T; Kildal, AB; Kittang, BR; Le, LAK; Lund-Johansen, F; Mathiessen, A; Mielnik, P; Müller, F; Nezvalova-Henriksen, K; Olsen, IC; Olsen, RB; Skåra, KH; Skei, NV; Skudal, H; Steffensen, A; Tholin, B; Thoresen, L; Tonby, K; Tran, T; Trøseid, M; Tveita, A; Ystrøm, CM | 1 |
| Del Vecchio, G; Durmaz, V; Labuz, D; Machelska, H; Massaly, N; Reidelbach, M; Rodriguez-Gaztelumendi, A; Sabri, P; Spahn, V; Stein, C; Temp, J; Weber, M | 1 |
1 review(s) available for adenosine monophosphate and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection.
Topics: Adenosine Monophosphate; Aged, 80 and over; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Emergency Service, Hospital; Humans; Length of Stay; Liver Diseases; Liver Function Tests; Male; Pandemics; Patient Discharge; Pneumonia, Viral; Respiratory Insufficiency; Severity of Illness Index; Treatment Outcome | 2020 |
1 trial(s) available for adenosine monophosphate and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Viral; Antiviral Agents; Biomarkers; Cause of Death; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Humans; Hydroxychloroquine; Inflammation; Male; Middle Aged; Norway; Oropharynx; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Standard of Care; Treatment Outcome; Viral Load | 2021 |
10 other study(ies) available for adenosine monophosphate and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
SARS-CoV-2 Associated Respiratory Failure in a Preterm Infant and the Outcome after Remdesivir Treatment.
Topics: Adenosine Monophosphate; Alanine; COVID-19 Drug Treatment; Humans; Infant; Infant, Newborn; Infant, Premature; Respiratory Insufficiency; SARS-CoV-2 | 2022 |
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Respiratory Insufficiency | 2023 |
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Middle Aged; Pandemics; Pneumonia, Viral; Receptors, Interleukin-1; Respiratory Insufficiency; SARS-CoV-2 | 2020 |
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hyperlipidemias; Intubation, Intratracheal; Obesity; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2; Treatment Outcome | 2020 |
COVID-19 and remdesivir in pediatric patients: the invisible part of the iceberg.
Topics: Adenosine Monophosphate; Alanine; Child; COVID-19 Drug Treatment; Humans; Respiratory Insufficiency; SARS-CoV-2; Thrombocytopenia | 2021 |
Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Compassionate Use Trials; COVID-19; Dexamethasone; Female; Fetal Organ Maturity; Glucocorticoids; Humans; Obesity; Oxygen Inhalation Therapy; Pregnancy; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Treatment Outcome | 2020 |
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Neutralizing; Antiviral Agents; Coronavirus Infections; COVID-19; Down Syndrome; Female; Heart Diseases; Humans; Immunization, Passive; Infant; Pandemics; Pneumonia, Viral; Respiratory Insufficiency | 2020 |
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Autoantibodies; Bronchoscopy; Child; COVID-19; COVID-19 Nucleic Acid Testing; Cyclophosphamide; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Methylprednisolone; Piperidines; Pneumonia, Pneumocystis; Pneumothorax; Pyrimidines; Respiratory Insufficiency; Shock, Septic; Subcutaneous Emphysema; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing.
Topics: Adenosine Monophosphate; Airway Management; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Hypoxia; Mortality; Patient Selection; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiratory Insufficiency; SARS-CoV-2; Time-to-Treatment; Treatment Outcome | 2021 |
A nontoxic pain killer designed by modeling of pathological receptor conformations.
Topics: Acute Pain; Adenosine Monophosphate; Analgesia; Analgesics, Opioid; Animals; Computer Simulation; Constipation; Drug Design; Fentanyl; Fluorescence Resonance Energy Transfer; GTP-Binding Protein alpha Subunits; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Ligands; Models, Molecular; Pain Management; Piperidines; Protein Binding; Protein Conformation; Rats; Receptors, Opioid, mu; Respiratory Insufficiency; Transfection | 2017 |